16 February 2025 - Poster Competition

16 Feb 2025 10:30 12:00
Foyer
Time Session
10:30
10:38
DNA ploidy, Stroma Fraction and Nucleotyping as potential predictive biomarkers for adjuvant Chemotherapy of stage II Colorectal Cancer: A Multicenter Cohort Study
AB-00116
Sanjun Cai Presenter
10:38
10:46
1st line treatment strategies in BRAF-V600E mutation mCRC patients: a clinical experience and real-world data from a single center
AB-00127
Chiang Shih Wei Presenter
10:46
10:54
Individualized Tumor-Informed Circulating Tumor DNA Analysis for Molecular Residual Disease Detection in Predicting Recurrence and Adjuvant Chemotherapy Efficacy in Colorectal Cancer
AB-0061
Di CAO Presenter
10:54
11:02
Review of Pseudomyxoma Peritoneii Treated by Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (CRS-HIPEC) , A Single Center Experience.
AB-00204
11:02
11:10
Measurement of CD8+ T cell-mediated anti-tumor immune response induced by neoadjuvant chemo-radiation therapy using T-cell receptor analysis in rectal cancer patient
AB-0014
Yong Joon Lee Presenter
11:10
11:18
Favorable long-term oncologic outcome of D3 lymph node dissection for clinical stage 2/3 right-sided colon cancer
AB-00157
Woong Bae Ji Presenter
11:18
11:26
Gut Microbiota Differences Between Colorectal Cancer Patients and Healthy Individuals: A Study in Central Taiwan
AB-00174
YuChen Chang Presenter
11:26
11:34
POLYREEN: A LOCALLY DEVELOPED ARTIFICIAL INTELLIGENCE SYSTEM FOR ENDOSCOPIC AUTOMATIC COLORECTAL POLYP DETECTION IN SARAWAK.
AB-00181
Loy Yuan Ling Presenter
11:32
11:40
Patient-derived Organoids from BRAFV600E-Mutated Colorectal Cancer Can Capture Tumor Heterogeneity and Direct Personalized Therapy
AB-00115
Fangqi Liu Presenter
11:40
11:52
Management of Malignant Rectal Polyps with Close Post-Polypectomy Margins Followed by Formal Total Mesorectal Excision – A Review of Local Experience
AB-00136
Gene Clyde Lim Presenter